Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116356) titled 'Molecular Characterization of Carbapenemase-Producing Enterobacterales' on Aug. 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Screening. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Sohag University
Condition:
Acute Myeloid Leukemia
Intervention:
Diagnostic Test: Antibiotic administration
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 10, 2025
Target Sample Size: 100
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/ct2/sho...